Background: A psychometric scale for assessing the distress that breast cancer patients experience due to the chemotherapy-induced alopecia was developed and validated.
introduction Anticancer substances such as doxorubicin, cytoxan, and taxotere-commonly used for breast cancer chemotherapy combinations [1] -result in various side-effects such as nausea, vomiting, weakness in the body, loss of appetite, hair loss, and possible neuropathy [2, 3] . These physical alterations and difficulties due to chemotherapy are notably associated with psychological disorders such as depression, anxiety, low self-esteem, and sexual disability, eventually resulting in low quality of life (QOL) in women with breast cancer [2, [4] [5] [6] [7] [8] [9] .
In the past two decades, there has been considerable growth in intensive research conducted on other side-effects related to chemotherapy, including nausea (e.g. new anti-nausea drugs) and fatigue (e.g. erythropoietin), and it has led to improvement in these symptoms. For example, nausea ranked 2nd in 1980s as the most painful side-effect among women with breast cancer but 11th in the 2000s [2, 10] ; however, during this same period, alopecia remained highly ranked among side-effects: 3rd in the 1980s and 2nd in the 2000s [2, 10] . In addition, despite the importance of hair loss, alopecia has rarely been the subject in the survivorship literature [11] .
Breast cancer patients describe hair loss as traumatizing and distressing [5, [12] [13] [14] [15] [16] [17] [18] , which was sometimes harder than losing a breast [18, 19] . Women have reported that alopecia is associated with a loss of privacy, because it makes the environment aware that the person is receiving chemotherapy [16, 19] . It is also a visible reminder of the disease [5, 13, 14] and confronts patients with the seriousness of cancer [5] . Some patients comment on hair loss negatively affecting social activities and interactions and as having an influence on willingness to continue working or creating apprehension about returning to work [16, 20, 21] . Hair loss was also feared because of the anticipation that it would affect social activities [22] . A change in the perception of the sense of self and self-esteem has also been reported [19, 23] . The decrease in sensuality and sexuality was also felt to be related to hair loss [19] .
Overall, research suggests that chemotherapy-induced alopecia (CIA) significantly impacts QOL and psychosocial adjustment among breast cancer patients. This side-effect emphasizes the necessity of systematic evaluation of the presence of associated distress and effects on other aspects of women's lives. However, to date, there is no disease-specific tool for measuring distress due to CIA with valid, reliable, and responsive questionnaires on perceptions of hair loss, QOL, psychological distress, sexuality, or social functioning. The need for such an instrument was noted in some scalp-cooling intervention studies because the general QOL surveys administered were not able to adequately capture these important issues. This study aims to develop and validate the Chemotherapy-induced Alopecia Distress Scale (CADS) for women with breast cancer.
methods participants
Study participants were recruited from 1 May to 30 August 2009 at breast cancer advocacy events held at 16 different hospitals in Korea. Subjects were eligible to participate in the study, if they were ≥18 years of age, had histologically confirmed and diagnosed with breast cancer (stage I-III), had no evidence of recurrence, metastasis, and had no evidence of psychological problems at the time of the survey. We excluded people who were unable to read Korean.
We approached 457 breast cancer patients; 353 of them (77.2%) agreed to participate in the study. Among them, people who had a psychological problem (n = 10), recurrence of the disease (n = 37), or who were stage 4 (n = 1) were excluded from the study, considering that they might experience different levels of CIA distress or other psychological problems. The final study population included 305 breast cancer patients (Table 1) . For testing the external validity of the CADS, we conducted a survey using another prospective study of 428 women with breast cancer at our institution in 2010. For the validation set, the same inclusion and exclusion criteria were applied, and the final sample for the validation set was 428. All procedures were approved by the Institutional Review Board of Samsung Medical Center, Korea, and all participants provided written informed consent.
instrument development
Before developing a questionnaire to assess CIA distress, an expert group consisted of two oncologists, three oncology nurses, one primary physician, and one behavior scientist carried out an extensive literature review, and confirmed that there was no existing instrument that specifically addressed CIA. Although there were studies on distress from CIA from the 1990s, previous studies had limitation to describe details of the distress due to CIA and its impact on QOL. Moreover, only a few studies included experiences of Asian or Korean women with breast cancer. Therefore, our study team decided to conduct a qualitative study to develop survey items; semi-structured in-depth interviews were conducted with 21 breast cancer patients to find out their perceptions, attitudes, preparedness, distress, and experience of CIA. Detailed methods and results of the qualitative study are described in other paper [20] . All patients thought that appearance was important and they had negative perceptions about alopecia; however, they were not well prepared regarding alopecia, and they experienced substantial physical, psychological, and social distress. Lack of information and limited social support, combined with negative images of cancer, made it more difficult for patients to overcome the trauma. At the end, it deterred patients' daily activities resulting in poor QOL.
Based on the literature review and the qualitative study, 33 items for assessing CIA were prepared. Six of the 33 items submitted to content experts in the first round were discarded; two additional items were discarded in the second round. Then, the survey (25 items) was pilot tested with 30 breast cancer patients who completed the survey and underwent a brief interview to answer questions similar to those used in the qualitative study. Feedback from those patients indicated that the survey addressed issues of importance to breast cancer patients in terms of CIA and that the instructions and (2) , emotional (9), daily activity (6), relationship (6) , and treatment (2)) was administered to the study participants. Respondents were instructed to indicate on a fourpoint Likert scale on each statement (1 = not at all, 2 = a little, 3 = quite a bit, and 4 = very much). Total scores were calculated by summing responses for all items; higher scores meant more distress due to CIA.
In addition to the CADS, we assessed patients' body image using EORTC BR-23, QOL with EORTC C-30, and self-esteem using the Rosenberg Self-Esteem Scale (RSE) to evaluate concurrent and discriminant validity [24, 25] . Sociodemographics and clinical characteristics-age, marital status, education, monthly family income, date of diagnosis, stage, current treatment, and surgery type-were also asked of study participants.
statistical analysis
Descriptive statistics were used for reporting characteristics of participants and mean and standard deviation (SD) of each item of the CADS. To evaluate construct validity, exploratory factor analysis was carried out to determine the underlying structure of the CADS. A common factor model with alpha factor extraction was used (Ferketich and Muller, 1990) . Alpha extraction generates its factors by finding the item groupings with maximum internal consistency, which makes it an appropriate choice for instrument development (Gorusch, 1983).
After extracting factor structure, we carried out confirmatory factor analysis (CFA) using the maximum likelihood with missing values to test whether our factor structure fit the data. Several goodness-of-fit indices were used to evaluate the model fit, including the goodness-of-fit index (GFI), comparative-fit-index(CFI), and standardized root mean-squared residual (SRMR). A GFI and CFI >0.9 and SRMR <0.08 indicate a good fit to the data [26, 27] . Factor loadings were categorized as low (<0.30), midrange (0.30-0.59), and high (≥0.60) [28] .
With regard to concurrent and discriminant validity, we expect CADS domain and total scores to at least moderately correlate with the body image (0.30 ≤ r ≥ 0.70) and also weaker correlations with the patient's overall QOL in the past week, and expected non-significant correlations with self-esteem.
To test internal consistency and reliability of the CADS, we calculated Cronbach's alpha on both derivation and validation data. We expected a value >0.70, which is the standard for defining acceptable reliability of an instrument. The significant level was at P < 0.05 (two-sided), and all statistical analyses were done using STATA software package 12.1 (STATA Corp., 4905 Lakeway Drive, College Station, TX).
results

study participants
The mean age (SD) of participants was 49.3 (7.9) years; 84.2% were married. In terms of education, 59.6% of participants had high school education, and 21.5% had more than college education. Of the total, 16.5% of the participants were currently working and rest of them were on leave of absence, retired, or housewives. There were 35.3% and 44.9% patients who had stage I and II breast cancer, respectively, and 41.6% of them were receiving either chemotherapy or radiotherapy at the time of the survey.
construct validity: factor analysis
The exploratory factor analysis indicated a four-factor solution with eigenvalue >1.0, while it was initially designed for a fivefactor solution. Two items (item 26 and 27) were initially designed for 'treatment' domain loaded on 'relationship' domain (Table 2 ). 
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According to the qualitative interview, breast cancer patients were least likely to concern these issues [20] , the study group decided to move these two items from the tool. In addition, we excluded three additional items (item 18, 19, and 21) which did not load significantly on an interpretable factor solution. The EFA resulted in the CADS with 20 items. The factor loadings for the four retained and varimax rotated factors are presented in Table 2 . The variance explained by the four-factor solution was 70.8%. Further examinations of the factor structure of the 20-item CADS were evaluated using the CFA; however, the model fit was not good due to correlated errors, and 3 items (items 4, 10, and 14) were excluded considering high content overlap. Then, we carried out another CFA, and it revealed high loadings (0.64-0.99) in general. The fit indices for this model were good: df = 113, χ 2 = 441.58, P < 0.001; CFI = 0.925; SRMR = 0.065 (Figure 1 ). 'Emotional" and 'Activity' highest correlation and 'Physical' and 'Relationship' showed the lowest correlation among four domains. The final version of the CADS with 17 items is in supplementary appendix 1, available at Annals of Oncology online.
Coefficient alpha was recalculated for the total CADS (0.95) and the four subscales ( Table 3 ). The Cronbach's alpha coefficients of the CADS and its subdomains were also very high, with the validation set confirming the external validity of the CADS (Table 3) . convergent and discriminant validity Table 4 shows the correlations among CADS, body image, overall QOL, and self-esteem. The total CADS moderately correlated with body image (r = −0.47, P < 0.001), weak correlated with overall QOL (r = −0.28, P < 0.001), and nonsignificant correlated with self-esteem (r = −0.07, P = 0.23).
discussion
In this study, CADS is a reliable and valid instrument for measuring distress due to chemotherapy-induced alopecia among Korean breast cancer patients. The four factors that emerged in this analysis are reflected in the four subdomains: physical, emotional, activity, and relationship. These subdomains reflect the findings of the previous qualitative study that evaluated distress of breast cancer patients because of hair loss during chemotherapy [20] . The EFA and CFA confirmed the construct validity of the tool. Concurrent and discriminant validity were demonstrated by its varying degree of correlations with body image, overall QOL, and self-esteem.
The CADS was easily administered and completed by breast cancer patients. Reliability was established by excellent internal consistency (Cronbach's alpha coefficient = 0.95 for total; 0.77-0.95 for subscales) and its validity was confirmed again with the validation dataset reporting Cronbach's alpha was 0.95 for total. The EFA and CFA confirmed our hypothesis regarding the underlying constructs of the CADS. The scale has four subscales: physical, emotional, activity, and relationship. The themes of the subscales were consistent with previous identified problems due to chemotherapy-induced alopecia [20] . The physical subscale presents physical pains and symptoms that patients experience due to alopecia and it covered actual problems caused by alopecia. Emotional, activity, relationships covered secondary problems caused by hair loss, including problems in intrapersonal and interpersonal relationship. Although these distresses would not be directly influenced by alopecia, they might be more difficult issues for breast cancer patients to cope with or solve. Therefore, health professionals should consider providing tailored physical and psychosocial support to improve distress induced by alopecia, including information provision, active patient empowerment education, and resource support (e.g. cosmetics, scarves, or wigs).
The finding that the CADS was more strongly associated with body image than with overall QOL seems appropriate, as the structure of alopecia distress is conceptually more closely related to body image than to QOL. Higher chemotherapy-induced distress would lead to worse body image; however, it is also true that patients with lower body image would have more alopecia distress like previous studies reported [4, 7, 29] . The absence of correlation with self-esteem attests to the discriminant validity of the CADS. Furthermore, this finding can be regarded as the advantage of measuring the structure of alopecia distress, as it indicated that the CADS rating is not influenced by the respondent's self-esteem.
One limitation must be mentioned: this study was carried out at a community event, and people who participated in the event and people who did not participate would be different. However, the response rate was relatively high and characteristics of the study population were fairly similar to those of Korean breast cancer patients in general. In addition, as this was developed based on Korean breast cancer patients, it would not be able to include all issues raised by women in other countries. However, according to the literature, women with breast cancer experience similar limitations and distress due to CIA, and we believe that the CADS could also be a reliable measure in other countries. Finally, we were not able to test known-group comparisons and test-rested due to data limitation, and further validation studies in different population and cultures would be necessary.
In conclusion, our study developed a reliable and valid scale for measuring chemotherapy-induced alopecia distress. This can be used not only to assess distress due to CIA but also to test the effectiveness of interventions for CIA management such as the cooling scarf.
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